News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
22,044 Results
Type
Article (1155)
Company Profile (1)
Press Release (20888)
Section
Business (11548)
Career Advice (36)
Deals (1443)
Drug Development (1649)
Employer Resources (2)
FDA (373)
Job Trends (503)
News (14431)
Policy (616)
Tag
Academia (18)
Allergies (1)
Alliances (745)
Alzheimer's disease (23)
Antibody-drug conjugate (ADC) (3)
Approvals (375)
Artificial intelligence (5)
Bankruptcy (7)
Best Places to Work (446)
Biotechnology (1)
Brain cancer (3)
Breast cancer (7)
Cancer (64)
Cardiovascular disease (7)
Career advice (26)
CAR-T (3)
Cell therapy (4)
Cervical cancer (2)
Clinical research (1469)
Collaboration (5)
Compensation (4)
COVID-19 (27)
CRISPR (1)
Cystic fibrosis (1)
Data (71)
Diabetes (5)
Diagnostics (215)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (1)
Duchenne muscular dystrophy (1)
Earnings (10785)
Employer resources (1)
Events (1724)
Executive appointments (6)
FDA (429)
Funding (17)
Gene editing (1)
Gene therapy (4)
GLP-1 (18)
Government (45)
Guidances (41)
Healthcare (539)
Infectious disease (29)
Inflammatory bowel disease (1)
Influenza (1)
Intellectual property (1)
Interviews (5)
IPO (1152)
Job creations (85)
Job search strategy (26)
Kidney cancer (1)
Labor market (2)
Layoffs (3)
Legal (165)
Liver cancer (2)
Lung cancer (8)
Lymphoma (6)
Manufacturing (5)
MASH (6)
Medical device (517)
Medtech (517)
Mergers & acquisitions (303)
Metabolic disorders (18)
Multiple sclerosis (4)
NASH (1)
Neurodegenerative disease (3)
Neuroscience (33)
NextGen: Class of 2025 (84)
Non-profit (37)
Obesity (4)
Opinion (1)
Ovarian cancer (1)
Pain (2)
Parkinson's disease (1)
Patents (2)
Patient recruitment (6)
Peanut (1)
People (575)
Phase I (369)
Phase II (566)
Phase III (563)
Pipeline (222)
Postmarket research (90)
Preclinical (146)
Prostate cancer (1)
Radiopharmaceuticals (6)
Rare diseases (8)
Real estate (98)
Regulatory (433)
Reports (4)
Research institute (30)
Resumes & cover letters (6)
RSV (2)
Schizophrenia (2)
Series A (2)
Series B (1)
Sickle cell disease (3)
Spinal muscular atrophy (4)
Startups (48)
Stomach cancer (1)
Vaccines (12)
Weight loss (5)
Women's health (1)
Date
Today (4)
Last 7 days (85)
Last 30 days (141)
Last 365 days (1318)
2025 (519)
2024 (1468)
2023 (1627)
2022 (1831)
2021 (1799)
2020 (1562)
2019 (1042)
2018 (845)
2017 (569)
2016 (337)
2015 (482)
2014 (333)
2013 (184)
2012 (6583)
2011 (388)
2010 (436)
Location
Africa (14)
Arizona (8)
Asia (1423)
Australia (129)
California (248)
Canada (103)
China (9)
Colorado (18)
Connecticut (12)
Delaware (9)
Europe (3027)
Florida (41)
Georgia (10)
Illinois (18)
Indiana (20)
Japan (2)
Kansas (2)
Kentucky (1)
Louisiana (4)
Maine (6)
Maryland (43)
Massachusetts (195)
Michigan (13)
Minnesota (16)
Missouri (1)
Montana (2)
Nevada (2)
New Hampshire (7)
New Jersey (90)
New York (73)
North Carolina (39)
Northern California (114)
Ohio (7)
Pennsylvania (69)
South America (36)
Southern California (108)
Tennessee (1)
Texas (27)
United States (1003)
Utah (16)
Virginia (5)
Washington D.C. (2)
Washington State (24)
Wisconsin (4)
22,044 Results for "138".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BriaCell Therapeutics Announces Closing of $13.8 million Public Offering
April 29, 2025
·
4 min read
Press Releases
BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering
April 25, 2025
·
3 min read
Press Releases
Takeda Awards $13.8 Million to U.S. Nonprofit Partners to Promote Healthy Eating and Expand STEM Education
April 30, 2025
·
1 min read
Press Releases
TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138
March 28, 2025
·
6 min read
Press Releases
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
January 31, 2025
·
4 min read
Press Releases
Disposable Syringes Market Size to Surpass USD 13.8 Billion By 2030
November 14, 2024
·
1 min read
Genetown
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
TransCode Therapeutics, Inc. today announced new preliminary data from its Phase 0 clinical trial with radiolabeled TTX-MC138 suggesting anti-tumor activity.
May 29, 2024
·
5 min read
Press Releases
TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial
December 18, 2024
·
6 min read
Genetown
TransCode Therapeutics Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138TTX-MC138 is Effective in Animal Models of Human Metastatic Pancreatic Cancer
TransCode Therapeutics, Inc. today reported successful completion of a preclinical study comprising four independent replicates with its lead therapeutic candidate, TTX-MC138, in pancreatic adenocarcinoma (PDAC).
December 12, 2023
·
6 min read
STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests
STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.
March 26, 2024
·
4 min read
1 of 2,205
Next
